Navigation Links
New prostate cancer screening guidelines face a tough sell, study suggests
Date:5/25/2012

isease early.

According to the USPSTF, evidence suggests the potential harms caused by PSA screening of healthy men as a means of identifying prostate cancer outweigh its potential to save lives and that routine annual screening should be eliminated in the healthy. Elevated PSA readings are not necessarily evidence of prostate cancer, and can lead to unnecessary prostate biopsy. In addition, even when biopsies reveal signs of prostate cancer cells, evidence shows that a large proportion will never cause harm, even if left untreated. The disease in older men often progresses slowly so that those who have it frequently die of other causes.

Treatments for prostate cancer can include the removal of the prostate, radiation or other therapies, each of which has the potential to cause serious problems like erectile dysfunction, complete impotence, urinary incontinence or bowel damage. And men who choose to "watch and wait" after elevated PSA readings must live with the anxiety of knowing they have an untreated cancer that could start to progress.

In the new study, Pollack and his colleagues found that while most physicians said they took age and life expectancy into account when deciding to order PSA screening, many also said they had a hard time estimating life expectancy in their patients and could use a better tool. H. Ballentine Carter, M.D., a professor of urology at Johns Hopkins and the senior investigator on the study, is planning to investigate the potential of individualized prostate cancer screening recommendations. Specifically, he and colleagues plan to create a decision-making tool that incorporates age, life expectancy, family history and prior PSA results in order to help doctors and their patients make better choices for prostate cancer screening.

In another report derived from results of Pollack's and Carter's survey, published in April in the Archives of Internal Medicine, the researchers say nearly half of the provid
'/>"/>

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds
2. Psychological Science explains uproar over prostate-cancer screenings
3. Scientists unravel role of fusion gene in prostate cancer
4. U.S. Advisers Say No to Routine PSA Tests for Prostate Cancer
5. Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk
6. Do Bald Men Face Higher Risk of Prostate Cancer?
7. Statins May Help Prevent Enlarged Prostate: Study
8. Scientists discover distinct molecular subtype of prostate cancer
9. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
10. Advanced Prostate Cancer Drug May Help at Earlier Stage
11. Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... NY (June 17, 2013) A team from the ... the Naomi Berrie Diabetes Center of Columbia University has ... reflect the features of maturity-onset diabetes of the young ... MODY patients to produce induced pluripotent stem (iPS) cells, ... a mouse, the stem cell-derived beta cells secreted insulin ...
(Date:6/17/2013)... 17, 2013 The Professional Center ... they are now open in Schertz. The ... counseling and access to educational support groups. , ... used to help with athletic performance, post traumatic ... center, Cheryl Camarillo, LCSW, works primarily with those ...
(Date:6/17/2013)... Pa. (PRWEB) June 17, 2013 Without ... worldwide is expected to almost double by 2025 to ... to join together to advance research for the debilitating ... innovative initiatives hold hope for a promising future in ... in research, focus on much-needed support for caregivers and ...
(Date:6/17/2013)... Toronto, Ontario (PRWEB) June 17, 2013 Reliable ... as it helps in having an internet portal that can ... to consider when they are executing their duties. Collecting fees ... if it is not carried out efficiently. In such cases, ... can ensure that the task can be carried out efficiently ...
(Date:6/17/2013)... 17, 2013 Registered Dietitian and Founder ... article today on Tatalou.com outlining her four ways to ... Tricks to Improve Memory ,” includes the benefits of ... video games. , Chevreau also introduces the importance ... in Brain Clarity, a product Chevreau created specifically ...
Breaking Medicine News(10 mins):Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Professional Center for Enhanced Performance Opens in Schertz 2Health News:World Leaders in Alzheimer’s Innovation to Discuss Progress, Collaboration at DIA Annual Meeting 2Health News:World Leaders in Alzheimer’s Innovation to Discuss Progress, Collaboration at DIA Annual Meeting 3Health News:World Leaders in Alzheimer’s Innovation to Discuss Progress, Collaboration at DIA Annual Meeting 4Health News:PayCanada Offers Link to Pay Services to its Customers 2Health News:4 Tricks to Improve Memory for Women 2
... Merit Medical,Systems, Inc. (Nasdaq: MMSI ), a ... in cardiology and radiology,procedures, announced today that the Company ... year ended December 31, 2007, after the,close of the ... will hold its investor conference call on the same ...
... Pharmaceuticals,Inc. (OTC Bulletin Board: LTUS) ("Lotus" or ... Republic of China ("PRC"), today,announced that Enze ... of Lotus, has implemented cost saving strategies, ... by approximately 50%., The environmentally-friendly strategies ...
... run on both conventional gasoline and stored electricity ... until more sustainable technology is developed, according to ... International Journal of Automotive Technology and Management, they ... slow development of more sustainable fuel-cell powered electric ...
... China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutical, Inc. ... Company"), a leading manufacturer and distributor of ... announced its CFO,Mr. Yizhao Zhang, will present ... Growth,Stock Conference in Dana Point, California., ...
... Moratorium on Bisphenol,A in Baby Bottles, Food and Beverage ... of state,and national environmental health organizations in the U.S. ... use of bisphenol A (BPA) in baby,bottles and other ... a,new study that demonstrates the toxic chemical BPA leaches ...
... 60 Percent Less ... Calories and Sugar, YUBA CITY, Calif., ... Growers Inc. has introduced,PlumSmart Light, a lower calorie version of the popular ... 11 grams of,sugar, PlumSmart Light is a delicious and fresh way to ...
Cached Medicine News:Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 2Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 3Health News:Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies 2Health News:The trouble with hybrids 2Health News:Shengtai Pharmaceutical, Inc. to Present at Roth Conference 2Health News:Shengtai Pharmaceutical, Inc. to Present at Roth Conference 3Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 3Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 4Health News:Sunsweet Introduces PlumSmart Light(R) 2
(Date:6/17/2013)... NEWPORT BEACH, Calif. , June 17, 2013 /PRNewswire-iReach/ ... healthcare financing options for consumers, including gastric bypass and ... hired additional staff in order to effectively contact as ... services. The increase in staff is all part of ... in order to assist patients with both good and ...
(Date:6/17/2013)... DEERFIELD, Ill. and OSAKA, Japan ... Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals ... NESINA (alogliptin) and the fixed-dose combination therapies KAZANO (alogliptin ... now available by prescription in pharmacies in ... approved by the U.S. Food and Drug Administration (FDA) ...
(Date:6/17/2013)... YORK , June 14, 2013 The law ... just commenced what is believed to be the first suit ... of pancreatic cancer in the user of two common anti-diabetic ... by Staten Island resident Robert ... Amylin Pharmaceuticals, LLC, et al., E.D.N.Y. CV 13-3411. ...
Breaking Medicine Technology:United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services 2United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services 3Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 2Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 3Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 4Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 5Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 6Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 7Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 8Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 9Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2
... (ERT), (Nasdaq: ERT ) a global ... to biopharmaceutical and healthcare organizations and the market leader ... in drug development, announced today results for the ... noted, all comparative numbers refer to changes from ...
... MOUNTAIN VIEW, Calif., Aug. 1, 2011 VIVUS, Inc. ... development and commercialization of novel therapeutic products, today reported its financial ... 2011. Second Quarter ResultsFor the second quarter ... million, or $0.20 per share, as compared to a net loss ...
Cached Medicine Technology:ERT Reports Second Quarter 2011 Operating Results 2ERT Reports Second Quarter 2011 Operating Results 3ERT Reports Second Quarter 2011 Operating Results 4ERT Reports Second Quarter 2011 Operating Results 5ERT Reports Second Quarter 2011 Operating Results 6ERT Reports Second Quarter 2011 Operating Results 7ERT Reports Second Quarter 2011 Operating Results 8ERT Reports Second Quarter 2011 Operating Results 9ERT Reports Second Quarter 2011 Operating Results 10ERT Reports Second Quarter 2011 Operating Results 11ERT Reports Second Quarter 2011 Operating Results 12ERT Reports Second Quarter 2011 Operating Results 13VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 2VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 3VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 4VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 5VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 6VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 7
CDIs Abdominal Binders are designed with a non-pitching, body contouring, non-rolling elastic band that provides both support and compression. Available in 9, 12 and 15 widths with waist ranges from ...
Ideal for abdominal and flank procedures....
Male high waisted compression girdle with CDIs Wonderfabric™...
CDIs 2nd Stage Abdominoplasty Girdle - a feminine, easy pull-on version of the 8000 series...
Medicine Products: